Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.960
-0.040 (-2.00%)
At close: Feb 21, 2025, 4:00 PM
2.000
+0.040 (2.04%)
After-hours: Feb 21, 2025, 4:47 PM EST
Boundless Bio Employees
Boundless Bio had 72 employees as of December 31, 2023.
Employees
72
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$848,042
Market Cap
43.71M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 72 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
BOLD News
- 19 days ago - Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer - GlobeNewsWire
- 2 months ago - Boundless Bio Announces Pipeline and Leadership Updates - GlobeNewsWire
- 3 months ago - Boundless Bio to Participate in the Piper Sandler Healthcare Conference - GlobeNewsWire
- 3 months ago - Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire
- 3 months ago - Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference - GlobeNewsWire
- 5 months ago - Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 6 months ago - Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 9 months ago - Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - Business Wire